CompletedPhase 2NCT02812342

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Yale University
Principal Investigator
Brett King, MD, PhD
Yale University
Intervention
Tofacitinib ointment(drug)
Enrollment
10 enrolled
Eligibility
18 years · All sexes
Timeline
20162018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02812342 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials